Maternal serum SHARP1 and hypoxia inducible factor-1α as biomarkers for preeclampsia

Serum Soluble Endoglin Versus Serum Placental Growth Factor for Early Prediction of Preeclampsia

Comparative study between levels of maternal serum Cell-Free Fetal DNA and Uric acid in pregnant women with and without Preeclampsia

Relation between plasma cell free fetal DNA level and uteroplacental blood flow in pre-eclamptic Women

High Serum Levels of Cardiac Troponin I., Tumor Necrosis Factor-Α and D-Dimer Could be Used as Early Predictors for Upcoming Preeclampsia and its Severity

Pregnancy-Associated Placental Protein A2/Placental Growth Factor Ratio Might Discriminate Normotensive Pregnant Women Who Are Liable to Develop Early-Onset Preeclampsia

Low Serum Pregnancy Protein 13 Early in Pregnancy might predict the oncoming Gestational Hypertensive Disorders, especially Early-onset Preeclampsia

Pregnancy-induced low serum Ficolin levels may underlie the development of Pre-eclampsia and predict it

First-Trimester Screening for Early and Late Preeclampsia using Maternal Characteristics, Maternal Serum Alpha-Fetoprotein and Estimated Placental Volume

Maternal serum placental growth factor and Preeclampsia